MAR PLUS

MAR PLUS ejes af STADA Arzneimittel AG (controlled by Bain Capital and Cinven) med hovedsæde i Tyskland. Nej. Den ultimative ejer af MAR PLUS, STADA Arzneimittel AG (controlled by Bain Capital and Cinven), har hovedsæde i Tyskland, ikke i USA.

STADA is a leading international pharmaceutical company focused on a three-pillar strategy consisting of generics, specialty pharma, and consumer healthcare products.

Ingen